PET/MRI在腹部与盆腔肿瘤中的应用
本文综述PET/MRI在腹部与盆腔肿瘤中的应用,指出其可同时采集PET与MRI图像并实现近乎完美的图像配准,互补信息优于PET/CT和单独MRI。文章概述PET/MRI与PET/CT的主要区别,并给出腹部和盆腔常见恶性肿瘤的病例示例和治疗方案。
要点
- PET/MRI将PET功能信息与MRI软组织对比结合,实现同步采集与近乎完美配准。
- MRI已越来越多用于前列腺、肝胆、胰腺、神经内分泌、宫颈和直肠癌的分期与再分期。
- 多种靶向放射性示踪剂的发展推动了PET/MRI在临床实践中的研究与应用。
核心结论
- PET/MRI同步采集可提供互补的影像信息,相比PET/CT和MR图像采集具有明显优势。
研究设计与样本
- 本文为综述,提供PET/MRI概述,包括与PET/CT主要差异的描述,以及腹部和盆腔常见恶性肿瘤的病例示例和治疗方案。
临床应用与阅片要点
- 在腹部和盆腔肿瘤的影像评估中,可关注PET/MRI同步采集所获得的互补信息,并了解其与PET/CT的差异。
- 对于前列腺、肝胆、胰腺、神经内分泌、宫颈和直肠癌等常见恶性肿瘤,可参考文中病例示例和治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
With PET/MRI, the strengths of PET and MRI are combined to allow simultaneous image acquisition and near-perfect image coregistration. MRI is increasingly being used for staging and restaging of abdominopelvic oncologic lesions, including prostate, hepatobiliary, pancreatic, neuroendocrine, cervical, and rectal cancers. Fluorine 18-fluorodeoxyglucose PET/CT has long been considered a cornerstone of oncologic imaging, and the development of multiple targeted radiotracers has led to increased research on and use of these agents in clinical practice. Thus, simultaneously performed PET/MRI enables the acquisition of complementary imaging information, with distinct advantages over PET/CT and MR image acquisitions. The authors provide an overview of PET/MRI, including descriptions of the major differences between PET/MRI and PET/CT, as well as case examples and treatment protocols for patients with commonly encountered malignancies in the abdomen and pelvis. Online supplemental material is available for this article. ©RSNA, 2021.
引用
- Galgano SJ, Calderone CE, Xie C, et al. Applications of PET/MRI in Abdominopelvic Oncology. Radiographics. 2021. PMID: 34597228. doi:10.1148/rg.2021210035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。